[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Spruce Biosciences Inc (SPRB)

Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spruce Biosciences Inc 611 GATEWAY BOULEVARD SUITE 740 SOUTH SAN FRANCISCO CA 94080 USA

www.sprucebiosciences.com Employees: 8 P: 415-655-4168

Sector:

Medical

Description:

Spruce Biosciences Inc. is a biopharmaceutical company. It focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy which are in clinical stage. Spruce Biosciences Inc. is based in Daly City, California.

Key Statistics

Overview:

Market Capitalization, $K 72,320
Enterprise Value, $K 23,410
Shares Outstanding, K 1,372
Float, K 1,313
% Float 95.70%
Short Interest, K 206
Short Float 15.04%
Days to Cover 1.74
Short Volume Ratio 0.20
% of Insider Shareholders 4.30%
% of Institutional Shareholders 91.71%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -38,970 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -12,270 K
EBIT, $ -34,010 K
EBITDA, $ -33,990 K

Growth:

1-Year Return 1,027.48%
3-Year Return -71.98%
5-Year Return -95.18%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 86.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -8.94 on 05/13/26
Next Earnings Date 08/13/26
Earnings Per Share ttm -36.60
EPS Growth vs. Prev Qtr 6.68%
EPS Growth vs. Prev Year 62.84%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-75 on 08/07/25

SPRB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -155.40%
Return-on-Assets % -101.67%
Profit Margin % 0.00%
Debt/Equity 0.19
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.04
Book Value/Share 25.29
Interest Coverage -432.00
60-Month Beta 3.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.